{
    "organizations": [],
    "uuid": "6127b10d397658571c6026ccaed5bf81bd6a81cf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kingworld-medicines-group-posts-fy/brief-kingworld-medicines-group-posts-fy-profit-attributable-of-rmb51-1-mln-idUSFWN1RA0WH",
    "ord_in_thread": 0,
    "title": "BRIEF-Kingworld Medicines Group Posts FY Profit Attributable Of RMB51.1 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Kingworld Medicines Group Ltd :\n* FY REVENUE DECREASED BY 2.1% TO RMB1.03 BILLION * FY ‚ÄçPROFIT ATTRIBUTABLE INCREASED 8.7% TO ABOUT RMB51.1 MILLION\n* BOARD RECOMMENDED DISTRIBUTION OF A FINAL DIVIDEND OF HK3.43 CENTS PER SHARE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T06:46:00.000+03:00",
    "crawled": "2018-03-29T15:33:18.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "kingworld",
        "medicine",
        "group",
        "ltd",
        "fy",
        "revenue",
        "decreased",
        "billion",
        "fy",
        "attributable",
        "increased",
        "million",
        "board",
        "recommended",
        "distribution",
        "final",
        "dividend",
        "cent",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}